In a recent preprint* uploaded to the bioRxiv server, researchers in the United States developed and tested a novel mucosal-administered adenoviral-vector vaccine christened "ChAd-SARS-CoV-2-S" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results